SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-038673
Filing Date
2023-08-07
Accepted
2023-08-04 18:51:42
Documents
17
Period of Report
2023-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20230801.htm   iXBRL 8-K 72513
2 EX-4.1 apvo-ex4_1.htm EX-4.1 190033
3 EX-4.2 apvo-ex4_2.htm EX-4.2 189874
4 EX-4.3 apvo-ex4_3.htm EX-4.3 195136
5 EX-10.1 apvo-ex10_1.htm EX-10.1 116215
6 EX-10.2 apvo-ex10_2.htm EX-10.2 399083
  Complete submission text file 0000950170-23-038673.txt   1434252

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20230801_lab.xml EX-101.LAB 14028
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20230801.xsd EX-101.SCH 2487
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20230801_pre.xml EX-101.PRE 10302
11 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20230801_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 231145282
SIC: 2834 Pharmaceutical Preparations